CLINICAL STUDY: HORMONE REPLACEMENT THERAPY
Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial
Peter Angerer, MDa,
Wolfgang Kothny, MDa,
Stefan Störk, MDa and
Clemens von Schacky, MDa
a Medizinische Klinik, Klinikum der Universität MünchenInnenstadt, München, Germany
Manuscript received February 4, 2000;
revised manuscript received May 17, 2000,
accepted July 12, 2000.
Reprint requests and correspondence: Dr. Peter Angerer, Medizinische Klinik, Klinikum der Universität MünchenInnenstadt, Ziemssenstr. 1, D-80336 München, Germany pangerer{at}medinn.med.uni-muenchen.de
OBJECTIVES
The study objective was to clarify in a randomized, controlled, observer-blind trial whether hormone replacement therapy (HRT) improves elastic properties of the common carotid artery in women with signs of subclinical atherosclerosis, especially in subgroups with increased risk, and whether less progestin enhances the effect.
BACKGROUND
Previous observational studies have yielded conflicting results on the influence of HRT on central arteries. Some studies reported improvement of distensibility by estrogen alone or in the subgroup of smokers.
METHODS
A total of 321 postmenopausal women were randomized to 1 mg 17ß-estradiol plus 0.025 mg gestodene for 12 days every month (HRT 1), or 1 mg 17ß-estradiol plus 0.025 mg gestodene for 12 days every third month (HRT 2), or no-HRT, during 48 weeks. In 173 women, distensibility of the common carotid artery was determined before and after therapy by M-mode ultrasound and brachial blood pressure measurement.
RESULTS
Change of distensibility was small and similar in the three treatment groups. In the subgroup of current smokers, HRT 2 (low progestin) increased distensibility by 32% (HRT 2: 8.2 ± 11.7; HRT 1: 0.6 ± 6.0; no HRT: 1.8 ± 6.8 x 103/kPa, p = 0.025 for no-HRT vs. HRT 2). In the subgroups with elevated blood pressure, high low density lipoprotein (LDL) cholesterol, or high age, no effect of HRT was detected.
CONCLUSIONS
This randomized intervention study demonstrates that long-term HRT with estrogen and progestin does not substantially influence distensibility of central arteries. Yet, in currently smoking postmenopausal women, HRT with low progestin seems to improve distensibility; this merits further study in a specifically designed trial.
|
Abbreviations and Acronyms
| | BMI | = body mass index | | CCA | = common carotid artery | | CHD | = coronary heart disease | | DC | = distensibility coefficient | | ECG | = electrocardiogram | | FSH | = follicle stimulating hormone | | HRT | = hormone replacement therapy | | IMT | = intima media thickness | | LDL | = low density lipoprotein cholesterol |
|
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Nilsson, P. Boutouyrie, and S. Laurent
Vascular Aging: A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention
Hypertension,
July 1, 2009;
54(1):
3 - 10.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. V. Nair, L. A. Chaput, E. Vittinghoff, D. M. Herrington, and for the Heart and Estrogen/Progestin Replacement S
Pulse Pressure and Cardiovascular Events in Postmenopausal Women With Coronary Heart Disease
Chest,
May 1, 2005;
127(5):
1498 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. V. Nair, D. Waters, W. Rogers, G. J. Kowalchuk, T. D. Stuckey, and D. M. Herrington
Pulse Pressure and Coronary Atherosclerosis Progression in Postmenopausal Women
Hypertension,
January 1, 2005;
45(1):
53 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Nguyen, D. R. Liles, P. H. Lin, and R. L. Bush
Hormone Replacement Therapy and Peripheral Vascular Disease in Women
Vascular and Endovascular Surgery,
November 1, 2004;
38(6):
547 - 556.
[Abstract]
[PDF]
|
 |
|
|